2. UroToday Home
  3. Video Lectures

Journal Club Videos

The Efficacy and Safety of Abiraterone Plus Prednisone, With or Without Radiotherapy, in Addition to Standard of Care (PEACE-1): Journal Club – Christopher Wallis & Zachary Klaassen
January 19, 2023
Details
5-Year Follow-Up Results From the STAMPEDE Randomised Trial: Abiraterone Acetate Plus Prednisolone for Metastatic Patients Starting Hormone Therapy: Journal Club – Christopher Wallis & Zachary Klaassen
January 19, 2023
Details
The Underrepresentation of Black and Hispanic Men in Clinical Trials Compared With Their Share of Prostate Cancer Incidence: Journal Club – Christopher Wallis & Zachary Klaassen
January 19, 2023
Details
What Urologists Need to Know: mpMRI for the Detection of Clinically Significant Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
January 12, 2023
Details
SALV-ENZA Trial: Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy Journal Club - Christopher Wallis & Zachary Klaassen
January 12, 2023
Details
Treatment-Specific Out-of-Pocket Costs for Patients Undergoing Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
January 5, 2023
Details
Differences in Mental Health Outcomes According to the Treatment Received for Men Being Treated with Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
January 5, 2023
Details
Using MRI to Safely Prevent Unnecessary Protocol-Advised Repeat Biopsy During Active Surveillance Journal Club - Christopher Wallis & Zachary Klaassen
January 5, 2023
Details
Comparing the Relative Benefits of Radiotherapy Dose Escalation ± Short-Term or Long-Term ADT as Treatment Intensification for Localized Prostate Cancer Journal Club - - Christopher Wallis & Zachary Klaassen
January 5, 2023
Details
Improvement in rPFS with Abiraterone Plus Olaparib Over Abiraterone Plus Placebo in First-Line mCRPC Irrespective of HRR Mutation Status, The PROpel Trial Journal Club - Christopher Wallis & Zachary Klaassen
December 21, 2022
Details
Sustained Benefit to Metastasis-Directed Therapy Versus Observation: A Pooled Analysis of the STOMP and ORIOLE Trials Journal Club - Christopher Wallis & Zachary Klaassen
December 20, 2022
Details
Nivolumab/Ipilimumab (Nivo/Ipi) with or Without CBM588 in Metastatic Renal Cell Carcinoma Journal Club - Christopher Wallis & Zachary Klaassen
December 15, 2022
Details
Atezolizumab as Adjuvant Therapy After Resection for Patients with Renal Cell Carcinoma with Increased Risk of Recurrence: IMmotion010 Trial - Journal Club - Christopher Wallis & Zachary Klaassen
December 15, 2022
Details
10-year Results DART 01-05, High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
December 15, 2022
Details
VIABLE Phase 3 Trial: Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With mCPRC, Journal Club - Christopher Wallis & Zachary Klaassen
December 5, 2022
Details
Electronic Symptom Monitoring During Cancer Treatment for Improved Quality of Life, Journal Club - Christopher Wallis & Zachary Klaassen
December 5, 2022
Details
223Ra Use Before 177Lu-PSMA for Patients with Bone-predominant mCRPC, The RAdium LUtetium (RALU) Study, Journal Club - Christopher Wallis & Zachary Klaassen
November 30, 2022
Details
Recovery and Morbidity After Robot-Assisted Radical Cystectomy With Intracorporeal Reconstruction vs Open Radical Cystectomy, the iROC Trial, Journal Club – Christopher Wallis & Zachary Klaassen
November 18, 2022
Details
Reducing Treatment Burden For Patients with Localized GG 2 or 3 Intermediate-Risk Prostate Cancer with MRI-Guided Focused Ultrasound Focal Therapy, Journal Club - Christopher Wallis & Zachary Klaassen
November 17, 2022
Details
18F-DCFPyL PET/CT Detection Rates in Patients with Biochemical Recurrent Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
November 15, 2022
Details
The Benefit of Adding Short-Term ADT to Prostate Bed Salvage Radiotherapy to Prevent Prostate Cancer Progression, The SPPORT Trial, Journal Club - Christopher Wallis & Zachary Klaassen
November 15, 2022
Details
An Association Between Lower Facility Level PSA Screening Rates and Higher Metastatic Prostate Cancer Incidence Rates, Journal Club - Christopher Wallis & Zachary Klaassen
November 10, 2022
Details
225Ac-PSMA-617 Post ADT in mCRPC Patients: Response to Treatment and Survival Analysis, Journal Club - Christopher Wallis & Zachary Klaassen
November 9, 2022
Details
Long-Term Follow-Up Results (CheckMate 9ER) Trial, Journal Club - Christopher Wallis & Zachary Klaassen
November 18, 2022
Details
EV-201 Enfortumab Vedotin After PD-1 or PD-L1 Inhibitors in Cisplatin-Ineligible Patients With Advanced Urothelial Carcinoma Journal Club – Christopher Wallis & Zachary Klaassen
October 12, 2022
Details
PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis, The PRIMARY Score - Journal Club - Christopher Wallis & Zachary Klaassen
October 6, 2022
Details
Trends in Incidence of Metastatic Prostate Cancer in the US - Christopher Wallis & Zachary Klaassen
October 6, 2022
Details
Optimal Treatment for Poor Prognosis Metastatic Castration-Resistant Prostate Cancer, Cabazitaxel vs Abi/Enza, Journal Club – Christopher Wallis & Zachary Klaassen
October 6, 2022
Details
Safety and Activity of Alpha-Emitting Ac-225-PSMA-617 Radioligand Therapy in mCRPC That Has Progressed After Lu-177-PSMA, Journal Club – Christopher Wallis & Zachary Klaassen
October 6, 2022
Details
The Clinical Trial Protocol of UpFront PSMA, Phase 2 Study of Sequential 177Lu‐PSMA‐617 and Docetaxel vs Docetaxel in Metastatic Hormone‐naïve Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
October 5, 2022
Details
Treatment Class-Specific Outcomes of Patients Receiving Immune Checkpoint Inhibitor vs Taxane Chemotherapy by Tumor Mutational Burden for mCRPC - Christopher Wallis & Zachary Klaassen
October 4, 2022
Details
The Role of Screening MRI To Detect Radiologic Evidence of Spinal Cord Compression With Subsequent Pre-Emptive Treatment in Men With Metastatic Castration-Resistant Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
October 3, 2022
Details
DNA Repair Genes Associated With Localized Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
September 29, 2022
Details
The Addition of Docetaxel to Radiotherapy and ADT in Nonmetastatic Unfavorable-Risk Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
January 29, 2022
Details
The Combination of PSMA + MRI vs to MRI Alone in the Diagnostic Performance for Detecting Clinically Significant Prostate Cancer (PRIMARY) - Christopher Wallis & Zachary Klaassen
September 27, 2022
Details
Molecular Subtyping and Neoadjuvant Chemotherapy in Bladder Cancer - Christopher Wallis & Zachary Klaassen
September 27, 2022
Details
Pembrolizumab Monotherapy for the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer Unresponsive to BCG the KEYNOTE-057 Study, Journal Club – Christopher Wallis & Zachary Klaassen
September 27, 2022
Details
Pembrolizumab Alone or Combined With Chemotherapy vs Chemotherapy As First-Line Therapy for Advanced Urothelial Carcinoma in the KEYNOTE-361 Trial Journal Club – Christopher Wallis & Zachary Klaassen
September 27, 2022
Details
CheckMate 274 Trial of Adjuvant Nivolumab vs Placebo in Patients Who Underwent Radical Surgery for High-Risk Muscle-Invasive Urothelial Carcinoma, Journal Club - Christopher Wallis & Zachary Klaassen
September 26, 2022
Details
CALGB 90601, Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma Journal Club - Christopher Wallis & Zachary Klaassen
September 26, 2022
Details
OMNIVORE - Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma, Journal Club - Christopher Wallis & Zachary Klaassen
September 25, 2022
Details
The Use of MRI With Targeted Biopsy in Prostate Cancer Screening Journal Club - Christopher Wallis & Zachary Klaassen
September 22, 2022
Details
225Actinium PSMA-617 and 177Lutetium PSMA-617 Tandem Therapy in mCRPC Patients, Journal Club – Christopher Wallis & Zachary Klaassen
September 22, 2022
Details
OLIGOPELVIS GETUG P07, Salvage Radiotherapy Combined With Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
September 21, 2022
Details
The First Multiplex Gene Expression Liquid Biopsy Assay to Assess Potential ARSI Resistant Mechanisms Simultaneously In the Treatment of Metastatic Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
September 21, 2022
Details
Is There Still a Role for Cytoreductive Nephrectomy? Analysis from the CARMENA Trial, Journal Club - Christopher Wallis & Zachary Klaassen
August 30, 2022
Details
Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic, Journal Club - Christopher Wallis & Zachary Klaassen
August 30, 2022
Details
Symptomatic and Health Related Quality of Life Benefits With Olaparib in Men With mCRPC Carrying Mutations in the Homologous Recombination Repair Genes, Journal Club - Christopher Wallis & Zachary Klaassen
May 24, 2022
Details
Combination Therapy Associated with Significantly Higher Rates of MFS Compared with ADT Alone Among Men with High-Risk Nonmetastatic Prostate Cancer: STAMPEDE Platform Protocol, Journal Club- Christopher Wallis & Zachary Klaassen
May 24, 2022
Details
Efficacy and Safety of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Defects (GALAHAD) Journal Club - Christopher Wallis & Zachary Klaassen
May 13, 2022
Details
The Benefit of ADT Treatment Intensification with Radiotherapy for Men with Localized Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
May 10, 2022
Details
PSMA PET CT Derived Risk-Stratification Tool for High-risk Prostate Cancer - a UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 30, 2022
Details
Racial and Ethnic Disparity in the Use of Prostate MRI - a UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 30, 2022
Details
Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence - UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 22, 2022
Details
Real-World Differences in Outcomes with First-Line Abiraterone Therapy Between African American and White Men with mCRPC - A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 22, 2022
Details
Higher Rates of Metastatic Disease on PSMA PET for Biochemical Recurrence Risk Groups, Journal Club - Christopher Wallis & Zachary Klaassen
April 14, 2022
Details
Health-Related Quality of Life- The ENZAMET Trial - A UroToday Journal Club –- Christopher Wallis & Zachary Klaassen
April 3, 2022
Details
ARASENS: A Phase 3 Trial of Darolutamide in Combination with Docetaxel for Men with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). Journal Club - Christopher Wallis & Zachary Klaassen
March 21, 2022
Details
Sequential Radiotherapy May Facilitate Deferral of Systemic Therapy Initiation in Oligometastatic Renal Cell Carcinoma, Journal Club - Christopher Wallis & Zachary Klaassen
January 19, 2022
Details
Risk Factors for Bladder Recurrence After Minimally Invasive Nephroureterectomy in UTUC, Journal Club- Christopher Wallis & Zachary Klaassen
January 19, 2022
Details
Treatment-Related Regret Among Men With Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
December 16, 2021
Details
The Efficacy of PARP inhibition in BRCA1- versus BRCA2-altered mCRPC, Journal Club - Christopher Wallis & Zachary Klaassen
December 14, 2021
Details
Variables Associated with the Use of Blue Light Cystoscopy Journal Club - Christopher Wallis & Zachary Klaassen
December 2, 2021
Details
NCCN Guideline Review on Prostate Cancer - Epidemiology, Initial Diagnosis, and Life Expectancy of Men With Prostate Cancer: Journal Club – Christopher Wallis & Zachary Klaassen
November 18, 2021
Details
NCCN Guidelines on Prostate Cancer Reviewing Advanced Prostate Cancer Neuroendocrine Disease, Bone and Visceral Metastases, and Treatment Sequencing – Christopher Wallis & Zachary Klaassen
November 12, 2021
Details
NCCN Prostate Cancer Clinical Practice Guidelines on Risk Stratification for Clinically Localized Prostate Cancer – Christopher Wallis & Zachary Klaassen
November 10, 2021
Details
Observation and Active Surveillance in the NCCN Prostate Cancer Guidelines- Christopher Wallis and Zachary Klaassen
November 9, 2021
Details
NCCN Guidelines - Staging Evaluation and Imaging Approaches in Prostate Cancer – Christopher Wallis and Zachary Klaassen
November 7, 2021
Details
NCCN Guidelines on Prostate Cancer Genetics - Christopher Wallis & Zachary Klaassen
October 31, 2021
Details
NCCN Guidelines on Prostate Cancer - A Focus on Chemotherapy, Immunotherapy, and Targeted Therapy in Advanced Prostate Cancer - Christopher Wallis and Zachary Klaassen
October 13, 2021
Details
NCCN Guidelines on Prostate Cancer: A Focus on Chemotherapy, Immunotherapy, and Targeted Therapy in Advanced Prostate Cancer - Chemotherapeutic Approaches - Christopher Wallis and Zachary Klaassen
October 13, 2021
Details
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer, The VISION Trial Journal Club - Christopher Wallis & Zachary Klaassen
October 6, 2021
Details
The Best Candidates for PSMA PET/CT as the Primary Staging Approach for High-risk Prostate Cancer - Christopher Wallis & Zachary Klaassen
October 1, 2021
Details
Long Term Use of Lutetium-177-PSMA Therapy for Men With Metastatic Castration-Resistant Prostate Cancer, Journal Club – Christopher Wallis & Zachary Klaassen
September 20, 2021
Details
Intermittent vs Continuous ADT for Patients A Review of the NCCN Guidelines – Christopher Wallis and Zachary Klaassen
September 13, 2021
Details
ADT for Castration-Naive Disease A Review of the NCCN Prostate Cancer Guidelines – Christopher Wallis and Zachary Klaassen
September 13, 2021
Details
The Cost-Effectiveness of PSMA-PET/CT When Compared with Conventional Imaging, An Analysis Informed by the proPSMA Trial - Journal Club - Christopher Wallis & Zachary Klaassen
September 10, 2021
Details
The Role of 18F-Fluciclovine-PET/CT in Improving Cancer Control Compared With Conventional Imaging Alone for Salvage Postprostatectomy Radiotherapy, the EMPIRE-1 Trial Journal Club – Christopher Wallis & Zachary Klaassen
September 10, 2021
Details
ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma Journal Club – Christopher Wallis & Zachary Klaassen
September 4, 2021
Details
NCCN Guidelines on Prostate Cancer: A Focus on Castration-Resistant Prostate Cancer - Christopher Wallis and Zachary Klaassen
August 31, 2021
Details
The NCCN Guidelines on Androgen Deprivation Therapy in Localized Disease, Regional Disease, and Palliative Treatment - Christopher Wallis and Zachary Klaassen
August 31, 2021
Details
Lenvatinib Plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma, The CLEAR Trial Journal Club - Christopher Wallis & Zachary Klaassen
August 12, 2021
Details
The Pattern of Metastatic Spread Impact on Efficacy of Enzalutamide - The ARCHES Study Journal Club - Christopher Wallis & Zachary Klaassen
August 12, 2021
Details
Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma, Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors: TROPHY-U-01 Journal Club – Christopher Wallis & Zachary Klaassen
July 30, 2021
Details
Durvalumab Combination in Advanced Urothelial Cancer based on an Adaptive Biomarker-driven Trial Design - Christopher Wallis & Zachary Klaassen
July 27, 2021
Details
Abiraterone Acetate Plus Prednisone in Black and White Men with Metastatic Castrate-Resistant Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
July 19, 2021
Details
A Phase 1 Trial and Biomarker Analysis of HIF-2α in Renal Cell Carcinoma With Belzutifan (MK-6482), Journal Club – Christopher Wallis & Zachary Klaassen
July 19, 2021
Details
Treatment Effect of 177Lu-PSMA in Low-Volume mHSPC Patients, Journal Club – Christopher Wallis & Zachary Klaassen
July 7, 2021
Details
18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer (CONDOR) Journal Club - Christopher Wallis & Zachary Klaassen
June 28, 2021
Details
Improved Survival for Men Treated With Enzalutamide Added to Testosterone Suppression Who Present With Distant Metastases Years After Diagnosis of mHSPC Journal Club – Christopher Wallis and Zachary Klaassen
June 21, 2021
Details
The BRAVO-Feasibility Study, Intravesical Maintenance BCG vs Radical Cystectomy in BCG-Naive Patients, A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
June 13, 2021
Details
A Systematic Review of the Effectiveness and Toxicities of Lutetium-177-labeled PSMA-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Journal Presentation - Christopher Wallis & Zachary Klaassen
June 4, 2021
Details
The Diagnostic Performance of PSMA PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY) - Christopher Wallis & Zachary Klaassen
June 1, 2021
Details
Practical Considerations For the Use of Switch Maintenance Therapy: Avelumab First-Line Maintenance in Locally Advanced or Metastatic Urothelial Carcinoma Journal Club - Christopher Wallis & Zachary Klaassen
June 1, 2021
Details
Metastasis-Directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
May 8, 2021
Details
The Decipher® Genomic Classifier for Recurrent Prostate Cancer in the NRG/RTOG 9601 Randomized Clinical Trial, Journal Club - Christopher Wallis & Zachary Klaassen
May 4, 2021
Details
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma a UroToday Journal Club - Christopher Wallis and Zachary Klaassen
April 13, 2021
Details
Survivorship Care Plans Addressing Long-term Mental Health Among Survivors of Testicular Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
March 30, 2021
Details
Real-World Treatment Patterns and Health Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer (mCRPC) - Christopher Wallis and Zachary Klaassen
February 19, 2021
Details
Stereotactic Ablative Body Radiotherapy in Patients in Oligometastatic Cancers: A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
February 4, 2021
Details
Racial Disparity and Outcomes Among US Patients with Cancer and COVID-19 A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
February 2, 2021
Details
Durvalumab Vs. Chemotherapy in Previously Untreated Patients with Unresectable Metastatic Urothelial Carcinoma (DANUBE) A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
February 2, 2021
Details
Extended 4-Year Followup of CheckMate 214 Trial, Nivolumab Plus Ipilimumab for First-Line Treatment of Advanced Renal Cell Carcinoma: A UroToday Journal Club - Christopher Wallis & Zachary Klaassen
January 29, 2021
Details
Timing of Radiotherapy After Radical Prostatectomy (RADICALS-RT) Journal Club - Zachary Klaassen and Christopher Wallis
January 24, 2021
Details
Imaging-Based Prostate Cancer Screening Among BRCA Mutation Carriers - A UroToday Journal Club
January 20, 2021
Details
Rucaparib in Men with Metastatic Castration-Resistant Prostate Cancer A Journal Club on the TRITON 2 Study - Christopher Wallis & Zachary Klaassen
January 17, 2021
Details
(TROG 08.03/ANZUP RAVES) Phase 3 Trial on Adjuvant Radiotherapy Versus Early Salvage Radiotherapy Following Radical Prostatectomy Journal Club - Christopher Wallis & Zachary Klaassen
January 2, 2021
Details
Adjuvant or Early Salvage Radiotherapy for the Treatment of Localized and Locally Advanced Prostate Cancer - The ARTISTIC Collaborative Journal Club - Christopher Wallis ad Zachary Klaassen
November 17, 2020
Details
First-Line Maintenance Avelumab in Patients with advanced Urothelial Carcinoma, A New Standard of Care - JAVELIN Bladder 100 Journal Club - Christopher Wallis & Zachary Klaassen
November 16, 2020
Details
Journal Club: Discussing Quality of Life in Patients with Metastatic Prostate Cancer Following Treatment with Cabazitaxel Versus Abiraterone or Enzalutamide - Christopher Wallis & Zachary Klaassen
October 16, 2020
Details
Significantly Longer Duration of Overall Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - PROfound Study Journal Club - Zachary Klaassen and Christopher Wallis
October 16, 2020
Details
Journal Club on Ureteroscopic Doppler Ultrasonography: Mapping Renal Blood Flow From Within the Collecting System- Evangelos Liatsikos and Roshan Patel
June 28, 2020
Details
Journal Club: The Efficacy and Safety of MitoGel™ (UGN-101) on Ablation of Upper Urinary Tract Urothelial Carcinoma (OLYMPUS) - Zachary Klaassen
June 22, 2020
Details
PROSPER Trial Journal Club: Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer - Zachary Klaassen and Christopher J.D. Wallis
June 19, 2020
Details
Journal Club: Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer - Zachary Klaassen
June 15, 2020
Details
The Impact of Treatment Delays of Upper Tract Urothelial Carcinoma (UTUC) During the COVID-19 Pandemic Journal Club - Zachary Klaassen
May 5, 2020
Details
Current and Emerging Therapies for Non-Muscle Invasive Bladder Cancer after BCG - Chris Wallis & Zach Klaassen
April 14, 2020
Details
Journal Club: The Evaluation of Cxbladder and Adjudication of Atypical Cytology - Sia Daneshmand
October 15, 2019
Details
Blue Light Cystoscopy for Diagnosis of Bladder Cancer - A Journal Club Review by Badrinath Konety
January 7, 2019
Details
Abiraterone Acetate for nmCRPC, The Forgotten Dance Partner? - Zach Klaassen and Chris Wallis
December 12, 2018
Details
email news signup